Stocks Health care RNA
NASDAQ · Health careAtrium Therapeutics, Inc. (RNA)
At June 30, 2026 it held $72.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Atrium Therapeutics, Inc. does
Atrium Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RNA.
Latest SEC filings
What Atrium Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026
- July 27, 2026Passive stake changed SCHEDULE 13G/A
- July 14, 2026Other event 8-K
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026
- May 14, 2026
Insider trades
What the people running Atrium Therapeutics, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 8 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 18, 2026 | Hoyos Rocio MartinChief Strategy Officer | Shares withheld for tax | 8,320 | $74.5K |
| September 18, 2026 | Winslow Brendan R.Chief Financial Officer | Shares withheld for tax | 6,742 | $60.3K |
| September 18, 2026 | Gallagher Kathleen P.See Remarks, Director | Shares withheld for tax | 11,632 | $104.1K |
| September 18, 2026 | Kenney StephanieSee Remarks | Shares withheld for tax | 2,375 | $21.3K |
| September 18, 2026 | Boyce SarahDirector | Shares withheld for tax | 126,418 | $1.1M |
| September 18, 2026 | Flanagan W. MichaelDirector | Shares withheld for tax | 22,812 | $204.2K |
| September 18, 2026 | Hughes Steven GeorgeChief Medical Officer | Shares withheld for tax | 21,459 | $192.1K |
| September 18, 2026 | Younis HusamChief Scientific Officer | Shares withheld for tax | 11,216 | $100.4K |
Questions about RNA
What does Atrium Therapeutics, Inc. do?
Atrium Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RNA.
When did Atrium Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 22, 2026.
Similar companies
Compare RNA with
Follow RNA
Get an email when Atrium Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow RNA: get an email when it filesWhere the numbers come from
Financial figures are the values Atrium Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.